Back to search

University of British Columbia

A deep learning approach for classification of pancreatic adenocarcinoma whole-slide pathology images

Abstract

dc:description

Pancreatic ductal adenocarcinoma (PDAC) mortality rates are projected to rise by 2030 due to factors such as delayed diagnosis and resistance to chemotherapy and radiation therapy. A key challenge in treating PDAC is the lack of biomarkers for predicting treatment effectiveness and chemotherapy resistance. Researchers suggest a binary subtype system, basal-like and classical, can predict treatment selection and response, but identifying these subtypes requires costly and time-consuming RNA profiling. Histopathology, which provides an inexpensive and convenient visual readout of disease biology, has been essential in cancer diagnosis and prognosis for over a century. Artificial intelligence (AI) has recently been successfully applied to histopathology data, with AI-based models potentially outperforming traditional pathology assessments. However, an AI expert is needed to utilize and interpret these techniques. This research aimed to: 1) develop an AI-based pipeline to identify and detect histological features for classifying PDAC molecular subtypes, and 2) generalize the pipeline using a “Machine Learning Workflow Engine” and a “Web-based Slide Manager and Annotator” for processing and interpreting histopathology data. The researchers used the developed infrastructures to train and evaluate a deep-learning model for classifying PDAC patients into prognostic subgroups. They used 130 histological slides from the TCGA-PAAD dataset for training and 81 slides from 19 patients from an in-house dataset as the external test dataset. A two-step machine learning model was trained: 1) a classifier distinguishing tumor patches from stroma patches, and 2) a classifier predicting the molecular subtype of a slide based on tumor patches. The tumor/stroma classifier showed excellent performance with an AUC of 96.18% ± 1.84%, while the subtype classifier achieved a balanced accuracy of 96.19% ± 2.45% at the slide level. The model correctly classified 83.03% ± 6.35 of the patients' tumor molecular subtypes in the validation cohort. This classifier is the first to categorize PDAC patients based on biopsy samples.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ahmadvand, Pouya
Contributors dc:contributor
  • Bashashati, Ali
  • Schaeffer, David F.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/84375

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ahmadvand, Pouya. A deep learning approach for classification of pancreatic adenocarcinoma whole-slide pathology images. master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/84375